Royalty Pharma

Royalty Pharma
Company typePublic
Nasdaq: RPRX
IndustryBiopharmaceuticals
Founded1996
FounderPablo Legorreta
HeadquartersNew York City, United States
Websitewww.royaltypharma.com

Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.

As of 2026, it is valued at $26.1 billion (£19.3 billion).

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.